Stellar Biotech (NASDAQ: SBOT) manufactures and sells Keyhole Limpet Hemocyanin (KLH) protein in the field of immunotherapy. KLH is an important immune-stimulating molecule widely used as an active pharmaceutical ingredient in many new immunotherapies, and as an injectable product to assess immune response.  Stellar’s customers and partners include multinational pharmaceutical companies, renowned research centers, and developers of active immunotherapies and therapeutic vaccines. The complexity and versatility of the KLH molecule, and growing need for commercial-scale GMP grade KLH, provide numerous commercial opportunities. For more information, visit the company’s website at www.stellarbiotechnologies.com